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Background. Electric-acoustic stimulation (EAS) is an excellent choice for people with residual hearing in low frequencies but not
high frequencies and who derive insufficient benefit from hearing aids. For EAS to be effective, subjects’ residual hearing must be
preserved during cochlear implant (CI) surgery.Methods. We implanted 6 subjects with a CI. We used a special surgical technique
and an electrode designed to be atraumatic. Subjects’ rates of residual hearing preservation were measured 3 times postoperatively,
lastly after at least a year of implant experience. Subjects’ aided speech perceptionwas tested pre- and postoperativelywith a sentence
test in quiet. Subjects’ subjective responses assessed after a year of EAS or CI experience. Results. 4 subjects had total or partial
residual hearing preservation; 2 subjects had total residual hearing loss. All subjects’ hearing and speech perception benefited from
cochlear implantation. CI diminished or eliminated tinnitus in all 4 subjects who had it preoperatively. 5 subjects reported great
satisfaction with their new device. Conclusions. When we have more experience with our surgical technique we are confident we
will be able to report increased rates of residual hearing preservation. Hopefully, our study will raise the profile of EAS in Brazil
and Latin/South America.
1. Introduction
Just over a decade ago people with sensorineural hearing loss
had 2 main hearing (re)habilitation options: (1) a hearing aid
(HA) if they had mild to moderate hearing loss and (2) a
cochlear implant (CI) if they had severe to profound hearing
loss. These 2 device options improved most users’ hearing.
However, people who could hear in the low frequencies (up
to 1000Hz) but not the medium and high frequencies—the
downward or “ski slope” audiogram—had too much high
frequency hearing loss to benefit from their hearing aid(s) but
were not CI candidates because surgeons feared the surgery
would destroy their residual hearing.
A solution for such people is electric-acoustic stimulation
(EAS), a concept developed by von Ilberg and colleagues in
1999 [1]. EAS provides synergistic unilateral acoustic (via the
HA) and electrical (via the CI) stimulation and provides its
users with better hearing than they had had with their HA or
HAs [2–4] and better hearing than enjoyed by unilateral CI-
only users [1–5], especially in noisy environments [2–4, 6–
9]. EAS also provides better sound quality and more natural
hearing than unilateral CIs or HAs [4, 10]. These benefits are,
however, only possible if surgeons do not damage the cochlea
(and thus the person’s residual hearing) during CI surgery.
To this end, technology and “soft surgical” techniques have
been—and are continuing to be—developed.
“Soft” surgery was first described by Lehnhardt and
Laszig in 1994 [11] and multiple surgeons and their teams
have since refined it [12–16]. Electrode insertion is of utmost
importance in atraumicity: the round window approach [15]
has shown to cause minimal cochlear damage and is thus
better for residual hearing preservation [4, 10].
Electrode design (shape, length, and bundle flexibility) is
also critical to reducing cochlear trauma [17–21]; both MED-
EL (Innsbruck, Austria) and Cochlear Limited (Sydney,
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Table 1: Subject demographics.
Subject number Age at implantation (years) Sex Duration of hearing loss (years) Insertion
1 63 M 5 Round window
2 62 M 10 Cochleostomy
3 40 F 10 Round window
4 29 M 8 Round window
5 42 M 20 Round window
6 46 M 15 Round window
Australia) have designed electrodes to meet this specific
need. Focusing on MED-EL’s FLEX24 (formerly known as
the FLEXEAS), as it is the electrode we used in our study,
recently surgeons have used it to achieve partial or complete
hearing preservation in 100% of their study subjects [10, 16].
Although such perfection is not always possible, regardless of
the surgeon’s skill or the implanted device’s technical wizardry
[22], it was our aim to preserve the residual hearing in each of
the 6 subjects we implanted betweenMarch 2010 andOctober
2011.
2. Materials and Methods
2.1. Subjects. 6 subjects (mean age 47 years) were implanted
with MED-EL cochlear implants with FLEX24 electrodes.
Study inclusion criteria were as follows: all subjects had to
(1) be older than 18 years, (2) have sensorineural bilateral
hearing loss with little or no benefit from HA (less than 40%
of auditory discrimination in monosyllables), (3) have pure-
tone thresholds of ≤60 dB hearing loss in at least 1 frequency
between 250 and 500Hz and of ≥80 dB in frequencies above
1000Hz, (4) have had stable hearing loss for at least the past
two years, and lastly (5) pass a psychological examination
ensuring they had realistic expectations about the potential
benefits of receiving a cochlear implant and/or using EAS
(Table 1). All subjects underwent pure tone audiometry
(PTA) and speech tests, pre- and postoperatively.
2.2. Surgical Technique. We used the same surgical technique
on all subjects. The technique, which we have named the
UNICAMP approach, is a mastoidectomy approach. It is
based on techniques developed in various otology centers.
2.3. Description of Surgical Technique. Patients were under
general anesthesia, tracheal intubation, and placed in a supine
position with their head turned to the contralateral side.
The operative field was prepared through extensive shaving,
cleaned with chlorhexidine 2%, and the attachment of the
electrodes to monitor CN VII.
We used a micropore to isolate the operative field from
the rest of the scalp and gave prophylaxis with cefazolin
(50mg/kg) intravenously during induction of anesthesia.
(1) The main landmarks are marked: tip of the mastoid,
temporal line, retroauricular incision line, area of the
internal component, and area of themicrophone with
the help of an implant template;
(2) antisepsis with 0.2% aqueous chlorhexidine, place-
ment of sterile drapes and steri-drape 2;
(3) rectilinear retroauricular incision and dissection
along anatomical planes; preparation of a “cross”
Palva flap (periosteal muscle) raising the four seg-
ments of the flap over the subperiosteal plane;
(4) removal of small fragments of fascia and temporal
muscle to occlude the cochleostomy;
(5) simplemastoidectomy, identifying the lateral semicir-
cular canal, the short ramus of the anvil, the posterior
wall of the outer ear canal, the tegmen timpani, and
the lateral sinus; gathering a small amount of bone
dust;
(6) thinning of the posterior wall of the outer ear canal,
posterior tympanotomy, preservation of the incus
buttress;
(7) preparation of the receiver bed for the implant on the
squamous portion of the temporal bone (well) using
a specific implant template;
(8) irrigation of the cavity with povidone-iodine (10%
povidone-iodine/1% active iodine) for two minutes
followed by abundant irrigationwith lactated Ringer’s
solution;
(9) irrigation of the cavity with ciprofloxacin (4mg/mL)
for two minutes followed by irrigation with lactated
Ringer’s solution;
(10) intravenous administration of dexamethasone (8mg)
before approaching the inner ear via a cochleostomy
or through the round window;
(11) application of topical triamcinolone (40mg/mL) over
the round window;
(12) opening the membrane of the round window; if this
approach is impossible, the endosteum is opened by
means of a cochleostomy;
(13) positioning of the implant into the prior drilled bed;
(14) Preparation of the fascia graft; making a pinhole
central orifice to allow the electrode to pass snugly to
be placed in the cochleostomy/round window site;
(15) insertion of the electrode slowly and continuously
during three minutes;
(16) positioning the muscle graft around the electrode to
seal the cochleostomy; placing bone dust to close the
posterior tympanotomy;
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Figure 1: Audiometric results for Subject 1.
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Figure 2: Audiometric results for Subject 2.
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Figure 3: Audiometric results for Subject 3.
(17) positioning the ground electrode under the muscle-
periosteum flap;
(18) closurewithVicryl 3.0 sutures on the Palva flap planes
and subcutaneous tissue; skin closure with Nylon 4.0;
(19) cleaning of the patient and placing an external com-
pressive dressing;
(20) impedance testing, neural response telemetry (NRT),
and a transorbital incidence radiograph are done to
confirm the position of the intracochlear electrode.
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Figure 5: Audiometric results for Subject 5.
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Figure 6: Audiometric results for Subject 6.
The same surgeon and surgical team performed all six
surgeries.
2.4. Audiometric Testing. All subjects had unaided pure-
tone audiometry tests at 250, 500, 1000, 2000, 3000, 4000,
6000, and 8000Hz (Figures 1–6). We used an AC30-SD25
audiometer, calibrated according to ISO 389/64.
To determine subjects’ residual hearing, we repeated the
unaided pure-tone audiometry tests at 250, 500, 1000, 2000,
3000, 4000, 6000, and 8000Hz three times: (1) at activation,
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Table 2: PTA tests of all subjects at all intervals: unaided.
Who Dates (days since previous test) 250Hz 500Hz 1 kHz 2 kHz 3 kHz 4 kHz 6 kHz 8 kHz
Subject 1
Preoperative: 01.06.2010 45 70 80 95 105 120 120 120
Activation: 22.09.2010 65 90 105 105 105 120 120 120
Post-op 2: 05.04.2011 (195) 65 95 100 105 110 120 120 120
Post op-3: 14.12.2011 (253) 65 95 100 105 110 120 120 120
Subject 2
Preoperative: 21.07.2010 50 65 100 110 115 120 120 120
Activation: 22.09.2010 90 105 115 120 120 120 120 120
Post-op 2: 13.04.2011 (203) 90 100 110 120 120 120 120 120
Post op-3: 07.12.2011 (238) 90 105 115 120 120 120 120 120
Subject 3
Preoperative: 22.09.2010 35 50 60 110 110 120 120 100
Activation: 13.12.2010 115 120 120 120 120 120 120 120
Post-op 2: 30.06.2011 (198) 120 120 120 120 120 120 120 120
Post op-3: 11.01.2012 (195) 120 120 120 120 120 120 120 120
Subject 4
Preoperative: 26.04.2011 55 65 105 120 120 120 120 100
Activation: 17.06.2011 65 75 95 105 120 120 120 120
Post-op 2: 11.01.2012 (208) 65 70 90 105 120 120 120 120
Post op-3: 18.09.2012 (251) 65 75 95 105 120 120 120 120
Subject 5
Preoperative: 11.10.2011 20 80 100 105 105 120 120 120
Activation: 13.12.2011 50 100 110 105 105 120 120 100
Post-op 2: 25.06.2012 (195) 50 105 110 105 110 120 120 100
Post op-3: 19.12.2012 (177) 50 100 110 105 105 120 120 100
Subject 6
Preoperative: 18.10.2011 50 45 80 90 95 105 105 100
Activation: 13.12.2011 80 80 95 105 105 110 110 100
Post-op 2: 18.07.2012 (218) 85 80 90 105 105 110 105 100
Post op-3: 08.01.2013 (174) 80 80 95 105 105 110 110 100
(2) 6.5–7 months after activation, and (3) approximately 7
months after their previous test.We defined “residual hearing
preservation” in three ways:
(1) “total hearing preservation”: a postoperative unaided
hearing loss of 0–10 dBs,
(2) “partial hearing preservation”: a postoperative
unaided hearing loss of >10 dB but leaving the
subject with ≤80 dB hearing or better in at least one
frequency between 250 and 1000Hz,
(3) “hearing preservation failure”: subject will not ben-
efit from EAS because their unaided postoperative
thresholds are >80 dB.
Lastly, to measure efficacy, all subjects had free field
warble tone tests with EAS or CI-only (depending on their
residual hearing) at the same postoperative intervals as were
their unaided tests.
2.5. Speech Perception Tests. Preoperatively, all subjects took
a speech perception test the same day as their implantation.
We used a speech perception sentence test based on one
developed by Bevilacqua et al. from several English language
tests [23]. Subjects did the test with their hearing aids on, in
a quiet place.
Postoperatively, all subjects repeated the speech percep-
tion test after at least 1 year of CI experience. Tests were done
in subject’s best-aided condition: EAS or CI-only, depending
on their postoperative residual hearing.The same audiologist
conducted all the pre- and postoperative tests.
2.6. Subjective Ratings. When the subjects did their postop-
erative speech tests they were asked to rate the quality of
their experience with EAS/a CI over the past year on a Likert
scale scored 0 to 10. A score of 0 indicated the user regretted
the intervention, would not recommend it to others, and felt
he/she had been better off in the past with their hearing aids.
A score of 10 indicated the user was completely satisfied with
the intervention and would strongly recommend it.
2.7. Ethics. The institutional review board approved this
study and all subjects gave written informed consent.
3. Results
All surgeries were uneventful. Although we planned to
implant all subjects via their round window, we could not
visualize subject 2’s round window and had to implant via
cochleostomy. All subjects received an implant with a MED-
EL FLEXEAS electrode. At no frequency or test interval did
any subject’s aided or unaided PTA score vary by more than
10 dB from their scores at the same frequency in either of the
other 2 tests. For the sake of convenience, the graphs show
their PTA scores at their last postoperative test (see Tables 2,
3, and Figure 7).
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Table 3: PTA tests of all subjects at all intervals: aided (EAS or CI on).
Who Dates (days since previous test) 250Hz 500Hz 1 kHz 2 kHz 3 kHz 4 kHz 6 kHz 8 kHz
Subject 1
Activation: 22.09.2010 35 35 30 25 40 35 35 45
Post-op 2: 05.04.2011 (195) 30 35 35 20 40 30 30 50
Post op-3: 14.12.2011 (253) 35 35 30 25 40 35 35 45
Subject 2
Activation: 22.09.2010 45 35 35 35 40 40 60 55
Post-op 2: 13.04.2011 (203) 40 40 35 40 40 40 55 50
Post op-3: 07.12.2011 (238) 45 35 35 35 40 40 60 55
Subject 3
Activation: 13.12.2010 45 60 60 50 40 70 55 55
Post-op 2: 30.06.2011 (198) 40 60 55 50 45 80 65 55
Post op-3: 11.01.2012 (195) 45 60 60 50 40 70 55 55
Subject 4
Activation: 17.06.2011 55 35 55 60 40 60 55 65
Post-op 2: 11.01.2012 (208) 65 25 55 65 40 60 55 60
Post op-3: 18.09.2012 (251) 55 35 55 60 40 70 55 65
Subject 5
Activation: 13.12.2011 30 60 65 60 60 70 55 70
Post-op 2: 25.06.2012 (195) 30 60 60 55 60 70 60 70
Post op-3: 19.12.2012 (177) 30 60 65 60 65 70 55 70
Subject 6
Activation: 13.12.2011 45 40 70 75 95 100 55 70
Post-op 2: 18.07.2012 (218) 40 40 65 75 100 110 55 70


























Figure 7: Pre- and Postoperative Speech Perception Scores. Note:
Subjects 1, 2, and 5 and 0% preoperative scores. ∗Median speech test
results pre-op: 4.0% (range 0% to 28%). ∗∗Median speech test results
post-op: 80.0% (range 16% to 84%).
All subjects’ speech perception was much better after
implantation (see Figure 7).
3.1. Subject 1. He had suffered from idiopathic hearing loss
for 5 years and had been using hearing aids for 2 years without
benefit. He had also been treated with corticosteroids but
experienced little improvement. He was fit with EAS with the
CI cut-off frequency set at 500Hz. His preoperative tinnitus
was not eliminated by surgery but is now, according to the
subject, no longer bothersome.
As you can see from his pre- and postoperative hearing
test results, he derived real benefit from implantation. We
achieved partial hearing preservation.
His speech perception test score improved from 0% pre-
operatively to 82% (with EAS) after 14 months CI experience.
He rated the quality of his experience a 9 on Likert scale,
indicating he was very pleased with the intervention.
3.2. Subject 2. He had suffered from idiopathic hearing loss
for 10 years and had been using hearing aids for 8 months
without benefit. Unlike the other 5 subjects, he was implanted
via cochleostomy instead of round window because we could
not visualize the round window.The subject was fit with a CI
only.
As you can see from his pre- and postoperative hearing
test results, he derived real benefit from implantation. We,
however, failed to preserve his residual hearing.
His speech test score improved from 0% preoperatively
to 16% (with CI-only) after 14 months CI experience. We
attribute this relatively poor speaking perception score to the
fact that he (1) lost (or had stolen) his external component
and so was without CI experience for approximately 11 of the
14.5 months between his activation and post-op speech test
and (2) he missed audiological rehabilitation sessions.
He rated the quality of his experience a 6 on the Likert
scale, indicating he was mildly pleased with the intervention.
3.3. Subject 3. She had suffered from idiopathic hearing loss
for 10 years and had been using hearing aids for the past
6 years, with little benefit. Her preoperative tinnitus and
dizziness were eliminated postoperatively. The subject was fit
with a CI only.
As you can see from her pre- and postoperative hearing
test results, she derived real benefit from implantation. We,
however, failed to preserve her residual hearing.
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Her speech test score improved from 28% preoperatively
to 78% (with CI-only) after 13 months CI experience.
She rated the quality of her experience a 9 on the Likert
scale, indicating she was very pleased with the intervention.
3.4. Subject 4. He had suffered from idiopathic hearing loss
for 8 years and had been using hearing aids for 4 years in
his right ear and 1 year in his left ear, with little benefit.
He had also been treated with corticosteroids, with little
improvement. The subject was fit with EAS with the CI cut-
off frequency set at 700Hz. His preoperative tinnitus and
dizziness were eliminated postoperatively.
As you can see from his pre- and post-op hearing
test results, he derived real benefit from implantation. We
achieved total residual hearing preservation.
His speech test score improved from 8% preoperatively to
84% (with EAS on) after 15 months CI experience.
He rated the quality of his experience a 10 on the
Likert scale, indicating he was extremely pleased with the
intervention.
3.5. Subject 5. He had suffered idiopathic hearing loss for
15 years and had using hearing aids for 5 years, with little
benefit. The subject was fit with EAS with the CI cut-
off frequency set to 350Hz. His preoperative tinnitus was
eliminated postoperatively.
As you can see from the pre- and postoperative data, he
derived real benefit from implantation. We achieved partial
residual hearing preservation.
His speech test score improved from 0% preoperatively to
82% (with EAS on) after 12 months CI experience.
He rated the quality of his experience a 10 on the
Likert scale, indicating he was extremely pleased with the
intervention.
3.6. Subject 6. He had suffered from idiopathic hearing loss
for 15 years and had been using hearing aids for 5 years, with
little benefit. The subject was fit with EAS with the CI cut-off
frequency set to 1 kHz.
As you can see from the pre- and postoperative hearing
test results, he derived some benefit from implantation. We
achieved partial residual hearing preservation.
His speech test score improved from 10% preoperatively
to 40% (with EAS) after 13 months CI experience. Despite
his relatively poor postoperative speech perception score, the
audiologist reports that he is improving.
He rated the quality of his experience an 8 on the Likert
scale, indicating he was very pleased with the intervention.
Some benefits of the good outcomes are represented by
the individual speech tests of all subjects (Tables 2, 3, and
Figure 7).
4. Discussion
Of our 6 subjects, 1 had total residual hearing preservation,
3 had partial residual hearing preservation, and 2 had total
residual hearing loss: a residual hearing preservation success
rate of 4/6. Looked at another way, postoperatively, 4 subjects
will benefit from EAS and 2 subjects (2 and 3) are no
longer partially deaf and thus no longer EAS candidates,
although they enjoy better hearing from their CI than they
had had from their HA before implantation. All subjects who
actually had 1-year implant experience had greatly improved
postoperative speech perception scores. 3 EAS users (subjects
1, 4, and 5) scored between 82% and 84%, similar to the results
of previous studies [8, 24]. Subject 6 scored poorer, only 40%
but is said to be improving. Subject 3, who was fitted CI
only, improved from 28% pre-op to 78% after 13 months CI
experience.
We demonstrated that cochlear implant surgery done
with the aim of preserving residual hearing is highly bene-
ficial to the hearing lives of the partially deaf—as evidenced
in their extremely positive Likert scale responses—evenwhen
we fail to preserve their residual hearing.We, nonetheless, fell
short of our lofty goal of 100% residual hearing preservation.
We attribute this to 2 primary causes. Firstly, living in and
working in Brazil, we have had very few EAS cases and
less experience with hearing preservation surgery than do
the surgeons whose results are featured in other articles.
EAS was developed in Germany as recently as 1999 and,
correspondingly, most experts come from Central Europe
(Gstoettner, von Ilberg, Lenarz, Skarzynski to name a few).
We (UNICAMP) are the only team in Brazil—a nation of
almost 200million—that does hearing preservation surgeries
like this. The surgical technique is difficult and we are
confident that with experience, and better-suited cases, we
will improve our success rate. Our results should be seen in
this context: a regional beginning.
Secondly, we had limited access to suitable EAS can-
didates. All subjects had idiopathic hearing loss and not
all of them were “true” EAS candidates. Subjects 1 and 5
had preoperative scores of 70 dB and 80 db, respectively, at
500Hz, whereas the maximum indication for EAS is 60 dB
at 500Hz. We implanted them anyway—as other surgical
teams have done [25, 26]—because they could still benefit
from EAS. If they had been “true” EAS candidates, their
postoperative hearing losses of 20–25 dB at 500Hz might
have appeared less severe.
Our residual hearing preservation results were below
those of other similar studies. Skarzynski et al. [27] partially
or totally preserved the hearing of 39/42 at 3months and from
34/40 to 36/40 at 13 months after surgery.They used standard
or FLEXSOFT electrodes and the hearing preservation round
window technique they developed and described in 2007 [15].
Arnoldner et al., achieved 11/11 residual hearing preservation
after a mean follow-up of 7.85 months. He used a round
windowor promontorium technique andFLEXEAS electrodes
[16]. Gstoettner et al. reported a success rate of 15/18 after up
to 12 months after EAS fitting [8]. They used the Frankfurt
surgical technique and MED-EL M-electrode.
Additionally, the provision of a CI decreased subjects’
tinnitus and dizziness. 4 subjects (1, 3, 4, and 5) suffered from
preoperative tinnitus. Postoperatively, only subject 1 still had
tinnitus, but he said it was “not too bad.” These results are
consistent with past studies [28–31], which found that CI
implantation usually eliminates or reduces tinnitus. Subjects
3 and 4’s preoperative dizziness disappeared after surgery.
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5. Conclusion
We strongly believe that EAS has an important place in the
future of otology. While it is entering its teenage years in
Central Europe, it is still in its infancy in Brazil. We hope
our results will raise the profile of EAS here and hearing
preservation surgery and help make it more common. Hope-
fully, with more experience and sufficient subjects, we—and
other new teams—will soon be reporting residual hearing
preservation results comparable to those of currently well-
established surgeons.
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